Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10060311HBVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS30087023HIVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS30074133HIVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20007384HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20007385HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20004195HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20065658HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20043075HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20024956HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20034877HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TCGA Plot Options
Drug Information
GeneINSR
DrugBank IDDB11567
Drug NameInsulin peglispro
Target IDBE0000033
UniProt IDP06213
Regulation Type
PubMed IDs27723227; 27512793
CitationsCusi K, Sanyal AJ, Zhang S, Hoogwerf BJ, Chang AM, Jacober SJ, Bue-Valleskey JM, Higdon AN, Bastyr EJ 3rd, Haupt A, Hartman ML: Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes. Diabetes Obes Metab. 2016 Oct;18 Suppl 2:50-58. doi: 10.1111/dom.12751.@@De Meyts P: The Insulin Receptor and Its Signal Transduction Network .
GroupsInvestigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBL